Bio Synergia Labs provides an extensible topical platform that uses advanced delivery technology to improve drug penetration, reduce irritation, and boost patient compliance.
Funding
Funding not disclosed
Founders
Product
Problem
Chronic skin conditions are currently treated with harsh, costly topical formulations that suffer from low patient adherence and fragmented distribution across prescription, over‑the‑counter, and aesthetic channels, leading to suboptimal outcomes.
Solution
Bio Synergia Labs offers an extensible topical platform that prioritizes delivery intelligence over active ingredients. By employing advanced, high‑efficacy delivery systems, the platform enhances drug penetration and patient compliance while remaining compatible with a wide range of current and future actives. Phase 1 delivers professional‑grade, high‑margin products for immediate skin‑health needs, and Phase 2 expands the system to integrate next‑generation regenerative and aesthetic innovations. This system‑level approach enables a single platform to support multiple indications and product lines, creating scalable value for both skin‑health and regenerative‑aesthetics markets.
Target Audience
Primary customers are dermatologists, aesthetic physicians, and skin‑care clinics seeking professional‑grade topical solutions that deliver superior efficacy and compliance.
Features
- Advanced delivery technology that improves active penetration and reduces irritation, boosting therapeutic efficacy
- Modular formulation architecture allowing easy integration of new actives and regenerative agents
- Professional‑grade product line designed for high‑margin, clinic‑based distribution
- Platform extensibility to support a broad spectrum of skin conditions and aesthetic applications over time
- Compatibility with both prescription and over‑the‑counter workflows, streamlining adoption across channels